This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Disappointments? Think Opportunities; Miracle Drug May Be Ailing Gilead: Jim Cramer's Best Blogs

NEW YORK (TheStreet) -- Jim Cramer fills his blog on RealMoney every day with his up-to-the-minute reactions to what's happening in the market and his legendary ahead-of-the-crowd ideas. This week he blogged on:

  • how not to give up on these big names, even though the market has, and
  • why a potent hepatitis C treatment is not a boon for shareholders.

Click here for information on RealMoney, where you can see all the blogs, including Jim Cramer's -- and reader comments -- in real time.


Disappointments? Think Opportunities

Posted at 3:43 p.m. EST on Thursday, April 24, 2014

Must Read: Jim Cramer: We Reach the Twilight Zone

What's the matter with Facebook (FB - Get Report)? Wasn't it the world's greatest quarter? Didn't it totally deliver on every metric? Doesn't it have accelerating revenue growth, increasing user engagement and the ultimate in worldwide reach?

[Read: Microsoft's 'Blowout Quarter' Proved Nothing]

Yes, it has all of that and much more. But here's what Facebook did best on the call: underpromise about the future. These guys basically spent a huge part of the call telling you that things are going to slow, that they aren't going to monetize things that we thought were about to be monetized and that in the end they are now just a company with really fast growth in earnings. This market doesn't just want really good earnings growth any more. It wants a dividend. It wants a buyback. It wants financial discipline. It doesn't want a company spending like a drunken sailor even as I get the sense that the sailor's really at the top of his game.

So the stock after opening strong didn't rally; it sold off.

Here's the rub. Unlike a lot of the stocks that have sold off because they are just a multiple of sales, not earnings, Facebook is actually an inexpensive stock. I don't know what's going to happen Friday with the stock. I do know that companies with tons of opportunities and great growth do reward their shareholders. I think this is an opportunity, not a disappointment.

I feel the same way about American Airlines Group (AAL). This $27 billion company, which has $10 billion in cash, reported magnificent sales and earnings Thursday morning. I can't believe how much money it made. It seemed like an aberration. And you know what? It was. It was aberrantly low because of all of the cancelled flights. Who knows what it can earn now that the skies are friendly. But it had the misfortune to report on the same day at United Continental (UAL) and that was the one airline, the only airline, that truly has delivered a nightmare number. It obliterated the glory of American. If the company had reported Wednesday, it probably would be through $40 instead of being "stuck" at $38.

[Read: Making Sense of the Crash in Amazon Stock]

Finally, there are two others that I am not giving up on even though the market sure has: Xilinx (XLNX) and Celgene (CELG - Get Report). These two stocks, both owned by my charitable trust, were obliterated Thursday and I am not happy. It's always nasty when you own a big loser. They make you feel like a loser. That's me -- a real loser because the trust owns these. Hey, I talk about the winners, bring on the losers.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Markets

Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Our Tweets

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs